Stock Price Movement and Market Context
On 6 Feb 2026, the stock touched an intraday low of Rs.11565.45, representing a 2.21% decline on the day. Despite this drop, it marginally outperformed its sector by 0.52%, indicating some relative resilience within the FMCG space. However, Procter & Gamble Hygiene & Health Care Ltd. is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a sustained downward momentum.
In comparison, the Sensex opened flat but moved into negative territory, trading at 83,212.55 points, down 0.12% from the previous close. The benchmark index remains 3.54% below its 52-week high of 86,159.02, with the 50-day moving average positioned above the 200-day moving average, suggesting a cautiously optimistic medium-term trend for the broader market.
Financial Performance and Valuation Metrics
Over the last five years, Procter & Gamble Hygiene & Health Care Ltd. has recorded a modest compound annual growth rate (CAGR) of 5.52% in net sales and 5.34% in operating profit. While these figures indicate steady growth, they fall short of the more robust expansion rates seen in some FMCG peers. The company’s return on equity (ROE) stands at an exceptionally high 92.3%, reflecting strong management efficiency and capital utilisation.
Despite this, the stock’s valuation appears stretched, with a price-to-book (P/B) ratio of 41.1, categorising it as very expensive relative to its book value. This elevated valuation has been a factor in the stock’s recent underperformance, as investors weigh the premium against growth prospects. The PEG ratio of 2.2 further suggests that the stock’s price growth has outpaced earnings growth, contributing to cautious sentiment.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Comparative Performance and Market Position
Procter & Gamble Hygiene & Health Care Ltd. has consistently underperformed the benchmark indices over recent years. Its one-year return of -18.10% contrasts sharply with the Sensex’s positive 6.60% gain over the same period. Furthermore, the stock has lagged behind the BSE500 index in each of the last three annual periods, underscoring a pattern of relative weakness.
Within the FMCG sector, the stock trades at a discount compared to the average historical valuations of its peers, which may reflect market concerns about its growth trajectory and valuation premium. The company’s market capitalisation grade is rated at 2, indicating a mid-tier market cap status within its sector.
Operational Highlights and Shareholding Structure
Despite the stock’s price challenges, the company reported strong quarterly results in December 2025. Net sales reached a quarterly high of Rs.1,261.90 crore, while PBDIT (profit before depreciation, interest, and taxes) also hit a record Rs.401.80 crore. The operating profit margin to net sales ratio stood at an impressive 31.84%, signalling effective cost management and profitability at the operational level.
Procter & Gamble Hygiene & Health Care Ltd. maintains a conservative financial structure, with an average debt-to-equity ratio of zero, indicating no reliance on debt financing. The majority shareholding remains with promoters, providing stability in ownership and strategic direction.
Is Procter & Gamble Hygiene & Health Care Ltd. your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Summary of Key Metrics
The stock’s Mojo Score currently stands at 43.0, with a Mojo Grade of Sell, downgraded from Hold on 17 Oct 2024. This reflects a reassessment of the company’s growth prospects and valuation in light of recent performance. The day’s price change was a modest 0.11%, indicating limited volatility despite the new low.
Dividend yield remains attractive at 3.14%, offering some income support to shareholders amid price declines. The 52-week high for the stock was Rs.14,679.80, highlighting the extent of the recent price correction.
Conclusion
Procter & Gamble Hygiene & Health Care Ltd.’s stock reaching a 52-week low of Rs.11565.45 underscores the challenges faced by the company in maintaining growth momentum and justifying its valuation premium. While operational profitability and management efficiency remain strong, the stock’s relative underperformance and stretched valuation metrics have weighed on investor sentiment. The company’s solid balance sheet and positive quarterly results provide a foundation, but the market continues to price in cautious expectations.
Unlock special upgrade rates for a limited period. Start Saving Now →
